Treatment of diseases due to infections and old age using anti-foaming agents.
The biochemical changes taking place in the organism in the course of ageing and infectious processes result in substantial catabolic processes during which a variety of gases are created (in addition to carbon dioxide and nitrogen, depending on the conditions, methane, ammonia, hydrogen sulphide, mercaptan, etc. are also created) in addition to peptides and low molecular organic compounds. These gases are dispersed in the extra-cellular space and in the capillary system of blood and lymph in the form of micro-foam. The accompanied disturbance in the ability to flow considerably impairs the immune defence system which is inseparably connected to the transport of catabolic products. Any resulting diseases can be alleviated or even removed by the application of a simple physical-chemical principle. Anti-foaming agents (solutions, all types of dispersions, micro-emulsions) based on polydimethylsiloxane but also based on fatty acid esters (preferably unsaturated fatty acids) are proposed for treatment purposes.
Reinemann
Peter Joachim
PJ
Windmuhlenstr. 14, D-28857, Syke, Germany. reinemann-syke@t-online.de
D000279:Administration, Cutaneous; D000544:Alzheimer Disease / Q000188:drug therapy*; D000934:Antifoaming Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004129:Dimethylpolysiloxanes / Q000008:administration & dosage / Q000627:therapeutic use*; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D007275:Injections, Intravenous; D009103:Multiple Sclerosis / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy; D012828:Silicones / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D000934:Antifoaming Agents; D004129:Dimethylpolysiloxanes; D005231:Fatty Acids, Unsaturated; D012828:Silicones; C013830:baysilon